Death receptors and caspases but not mitochondria are activated in the GDNF-or BDNF-deprived dopaminergic neurons

Journal of Neuroscience

Volumn 28, Issue 30, 2008, Pages 7467-7475

  Yu, Li Ying ^a   Saarma, Mart ^a   Arumäe, Urmas ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Apoptosis; Caspases; Dopaminergic neurons; Fas; GDNF, BDNF

Indexed keywords

BENZYLOXYCARBONYLASPARTYL FLUOROMETHYL KETONE; BRAIN DERIVED NEUROTROPHIC FACTOR; CASPASE; CASPASE 3; CASPASE 7; CASPASE 8; CASPASE 9; CASPASE INHIBITOR; CYTOCHROME C; DEATH RECEPTOR; FAS ASSOCIATED DEATH DOMAIN PROTEIN; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; ISOPROTEIN; NEUROTROPHIC FACTOR; PROTEIN BAX; PROTEIN BCL XL; UNCLASSIFIED DRUG; BUTYLOXYCARBONYL O METHYL ASPARTYL FLUOROMETHYL KETONE; BUTYLOXYCARBONYL-O-METHYL-ASPARTYL-FLUOROMETHYL KETONE; CELL NUCLEUS ANTIGEN; DNA BINDING PROTEIN; DOPAMINE; ENHANCED GREEN FLUORESCENT PROTEIN; ENZYME INHIBITOR; GREEN FLUORESCENT PROTEIN; HOMEOBOX PROTEIN PITX3; HOMEODOMAIN PROTEIN; KU ANTIGEN; PEPTIDE CHLOROMETHYL KETONE; PROTEIN BCL X; STAUROSPORINE; TRANSCRIPTION FACTOR; TYROSINE 3 MONOOXYGENASE;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; CHIMERA; CONTROLLED STUDY; CYTOSOL; DOPAMINERGIC NERVE CELL; EMBRYO; EMBRYO CELL; ENZYME ACTIVATION; GENE OVEREXPRESSION; MESENCEPHALON; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; ANALYSIS OF VARIANCE; ANIMAL; CELL CULTURE; CYTOLOGY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; IMMUNOPRECIPITATION; METABOLISM; METHODOLOGY; MOUSE; NERVE CELL; NEWBORN; PHYSIOLOGY;

AMINO ACID CHLOROMETHYL KETONES; ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; ANTIGENS, NUCLEAR; BCL-X PROTEIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CASPASES; CELLS, CULTURED; DNA-BINDING PROTEINS; DOPAMINE; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; GREEN FLUORESCENT PROTEINS; HOMEODOMAIN PROTEINS; IMMUNOPRECIPITATION; MESENCEPHALON; MICE; MITOCHONDRIA; NEURONS; RECEPTORS, DEATH DOMAIN; STAUROSPORINE; TRANSCRIPTION FACTORS; TRANSFECTION; TYROSINE 3-MONOOXYGENASE;

EID: 50549103561     PISSN: 02706474     EISSN: 02706474     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.1877-08.2008     Document Type: Article

References (58)

1. Airaksinen MS, Saarma M (2002) The GDNF family: signalling, biological functions and therapeutic value. Nat Rev Neurosci 3:383-394.
2. Baliga BC, Read SH, Kumar S (2004) The biochemical mechanism of caspase-2 activation. Cell Death Differ 11:1234-1241.
3. Bao Q, Shi Y (2007) Apoptosome: a platform for the activation of initiator caspases. Cell Death Differ 14:56-65.
4. Baquet ZC, Bickford PC, Jones KR (2005) Brain-derived neurotrophic factor is required for the establishment of the proper number of dopaminergic neurons in the substantia nigra pars compacta. J Neurosci 25:6251-6259.
5. Barde YA (1989) Trophic factors and neuronal survival. Neuron 2:1525-1534.
6. Bespalov MM, Saarma M (2007) GDNF family receptor complexes are emerging drug targets. Trends Pharmacol 28:68-74.
7. Boatright KM, Renatus M, Scott FL, Sperandio S, Shin H, Pedersen IM, Ricci JE, Edris WA, Sutherlin DP, Green DR, Salvesen GS (2003) A unified model for apical caspase activation. Mol Cell 11:529-541.
8. Bredesen DE, Rao RV, Mehlen P (2006) Cell death in the nervous system. Nature 443:796-802.
9. Burke RE, Antonelli M, Sulzer D (1998) Glial cell line-derived neurotrophic growth factor inhibits apoptotic death of postnatal substantia nigra dopamine neurons in primary culture. J Neurochem 71:517-525.
10. Chang LK, Putcha GV, Deshmukh M, Johnson EM Jr (2002) Mitochondrial involvement in the point of no return in neuronal apoptosis. Biochimie 84:223-231.
11. Danial NN, Korsmeyer SJ (2004) Cell death. Critical control points. Cell 116:205-219.
12. Gill SS, Patel NK, Hotton GR, O'Sullivan K, McCarter R, Bunnage M, Brooks DJ, Svendsen CN, Heywood P (2003) Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat Med 9:589-595.
13. Gogvadze V, Orrenius S, Zhivotovsky B (2006) Multiple pathways of cytochrome c release from mitochondria in apoptosis. Biochim Biophys Acta 1757:639-647.
14. Granholm AC, Reyland M, Albeck D, Sanders L, Gerhardt G, Hoernig G, Shen L, Westphal H, Hoffer B (2000) Glial cell line-derived neurotrophic factor is essential for postnatal survival of midbrain dopamine neurons. J Neurosci 20:3182-3190.
15. Guo Y, Srinivasula SM, Druilhe A, Fernandes-Alnemri T, Alnemri ES (2002) Caspase-2 induces apoptosis by releasing proapoptotic proteins from mitochondria. J Biol Chem 277:13430-13437.
16. Gyrd-Hansen M, Farkas T, Fehrenbacher N, Bastholm L, Høyer-Hansen M, Elling F, Wallach D, Flavell R, Kroemer G, Nylandsted J, Jää ttelä M (2006) Apoptosome-independent activation of the lysosomal cell death pathway by caspase-9. Mol Cell Biol 26:7880-7891.
17. Hartmann A, Troadec JD, Hunot S, Kikly K, Faucheux BA, Mouatt-Prigent A, Ruberg M, Agid Y, Hirsch EC (2001) Caspase-8 is an effector in apoptotic death of dopaminergic neurons in Parkinson's disease, but pathway inhibition results in neuronal necrosis. J Neurosci 21:2247-2255.
18. Hartmann A, Mouatt-Prigent A, Faucheux BA, Agid Y, Hirsch EC (2002) FADD: a link between TNF family receptors and caspases in Parkinson's disease. Neurology 58:308-310.
19. Jackson-Lewis V, Vila M, Djaldetti R, Guegan C, Liberatore G, Liu J, O'Malley KL, Burke RE, Przedborski S (2000) Developmental cell death in dopaminergic neurons of the substantia nigra of mice. J Comp Neurol 424:476-488.
20. Jain S, Golden JP, Wozniak D, Pehek E, Johnson EM Jr, Milbrandt J (2006) RET is dispensable for maintenance of midbrain dopaminergic neurons in adult mice. J Neurosci 26:11230-11238.
21. Janec E, Burke RE (1993) Naturally occurring cell death during postnatal development of the substantia nigra pars compacta of rat. Mol Cell Neurosci 4:30-35.
22. Johnson EM Jr, Deckwerth TL (1993) Molecular mechanisms of developmental neuronal death. Annu Rev Neurosci 16:31-46.
23. Kahns S, Kalai M, Jakobsen LD, Clark BFC, Vandenabeele P, Jensen PH (2003) Caspase-1 and caspase-8 cleave and inactivate cellular parkin. J Biol Chem 278:23376-23380.
24. Kramer ER, Aron L, Ramakers GM, Seitz S, Zhuang X, Beyer K, Smidt MP, Klein R (2007) Absence of Ret signaling in mice causes progressive and late degeneration of the nigrostriatal system. PLoS Biol 5:e39.
25. Krieglstein K (2004) Factors promoting survival of mesencephalic dopaminergic neurons. Cell Tissue Res 318:73-80.
26. Krieglstein K, Maysinger D, Unsicker K (1996) The survival response of mesencephalic dopaminergic neurons to the neurotrophins BDNF and NT-4 requires priming with serum: comparison with members of the TGF-beta superfamily and characterization of the serum-free culture system. J Neural Transm Suppl 47:247-258.
27. Lang AE, Gill S, Patel NK, Lozano A, Nutt JG, Penn R, Brooks DJ, Hotton G, Moro E, Heywood P, Brodsky MA, Burchiel K, Kelly P, Dalvi A, Scott B, Stacy M, Turner D, Wooten VG, Elias WJ, Laws ER, et al. (2006) Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease. Ann Neurol 59:459-466.
28. Lassus P, Opitz-Araya X, Lazebnik Y (2002) Requirement for caspase-2 in stress-induced apoptosis before mitochondrial permeabilization. Science 297:1352-1354.
29. Lesné S, Blanchet S, Docagne F, Liot G, Plawinski L, MacKenzie ET, Auffray C, Buisson A, Piétu G, Vivien D (2002) Transforming growth factor-beta1-modulated cerebral gene expression. J Cereb Blood Flow Metab 22:1114-1123.
30. Lin LF, Doherty DH, Lile JD, Bektesh S, Collins F (1993) GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260:1130-1132.
31. Lindholm P, Voutilainen MH, Laurén J, Peränen J, Leppänen VM, Andressoo JO, Lindahl M, Janhunen S, Kalkkinen N, Timmusk T, Tuominen RK, Saarma M (2007) Novel neurotrophic factor CDNF protects and rescues midbrain dopamine neurons in vivo. Nature 448:73-77.
32. McDonnell MA, Wang D, Khan SM, Vander Heiden MG, Kelekar A (2003) Caspase-9 is activated in a cytochrome c-independent manner early during TNFalpha-induced apoptosis in murine cells. Cell Death Differ 10:1005-1015.
33. Mehlen P, Rabizadeh S, Snipas SJ, Assa-Munt N, Salvesen GS, Bredesen DE (1998) The DCC gene product induces apoptosis by a mechanism requiring receptor proteolysis. Nature 395:801-804.
34. Meuer K, Suppanz IE, Lingor P, Planchamp V, Göricke B, Fichtner L, Braus GH, Dietz GPH, Jakobs S, Bähr M, Weishaupt JH (2007) Cyclin-dependent kinase 5 is an upstream regulator of mitochondrial fission during neuronal apoptosis. Cell Death Differ 14:651-661.
35. Mijatovic J, Airavaara M, Planken A, Auvinen P, Raasmaja A, Piepponen TP, Costantini F, Ahtee L, Saarma M (2007) Constitutive Ret activity in knock-in multiple endocrine neoplasia type b mice induces profound elevation of brain dopamine concentration via enhanced synthesis and increases the number of TH-positive cells in the substantia nigra. J Neurosci 27:4799-4809.
36. Nunes I, Tovmasian LT, Silva RM, Burke RE, Goff SP (2003) Pitx3 is required for development of substantia nigra dopaminergic neurons. Proc Natl Acad Sci U S A 100:4245-4250.
37. Oo TF, Kholodilov N, Burke RE (2003) Regulation of natural cell death in dopaminergic neurons of the substantia nigra by striatal glial cell line-derived neurotrophic factor in vivo. J Neurosci 23:5141-5148.
38. Oo TF, Ries V, Cho J, Kholodilov N, Burke RE (2005) Anatomical basis of glial cell line-derived neurotrophic factor expression in the striatum and related basal ganglia during postnatal development of the rat. J Comp Neurol 484:57-67.
39. Oppenheim RW (1991) Cell death during development of the nervous system. Annu Rev Neurosci 14:453-501.
40. Peter ME, Krammer PH (2003) The CD95(APO-1/Fas) DISC and beyond. Cell Death Differ 10:26-35.
41. Peter ME, Budd RC, Desbarats J, Hedrick SM, Hueber AO, Newell MK, Owen LB, Pope RM, Tschopp J, Wajant H, Wallach D, Wiltrout RH, Zörnig M, Lynch DH (2007) The CD95 receptor: apoptosis revisited. Cell 129:447-450.
42. Pop C, Timmer J, Sperandio S, Salvesen GS (2006) The apoptosome activates caspase-9 by dimerization. Mol Cell 22:269-275.
43. Putcha GV, Harris CA, Moulder KL, Easton RM, Thompson CB, Johnson EM Jr (2002) Intrinsic and extrinsic pathway signaling during neuronal apoptosis: lessons from the analysis of mutant mice. J Cell Biol 157:441-453.
44. Raoul C, Henderson CE, Pettmann B (1999) Programmed cell death of embryonic motoneurons triggered through the fas death receptor. J Cell Biol 147:1049-1062.
45. Raoul C, Buhler E, Sadeghi C, Jacquier A, Aebischer P, Pettmann B, Henderson CE, Haase G (2006) Chronic activation in presymptomatic amyotrophic lateral sclerosis (ALS) mice of a feedback loop involving Fas, Daxx, and FasL. Proc Natl Acad Sci U S A 103:6007-6012.
46. Riedl SJ, Salvesen GS (2007) The apoptosome: signalling platform of cell death. Nat Rev Mol Cell Biol 8:405-413.
47. Robertson JD, Gogvadze V, Kropotov A, Vakifahmetoglu H, Zhivotovsky B, Orrenius S (2004) Processed caspase-2 can induce mitochondria-mediated apoptosis independently of its enzymatic activity. EMBO Rep 6:643-648.
48. Sawada M, Sun W, Hayes P, Leskov K, Boothman DA, Matsuyama S (2003a) Ku70 suppresses the apoptotic translocation of Bax to mitochondria. Nat Cell Biol 5:320-329.
49. Sawada M, Hayes P, Matsuyama S (2003b) Cytoprotective membrane-permeable peptides designed from the Bax-binding domain of Ku70. Nat Cell Biol 5:352-357.
50. Segura MF, Sole C, Pascual M, Moubarak RS, Perez-Garcia MJ, Gozzelino R, Iglesias V, Badiola N, Bayascas JR, Llecha N, Rodriguez-Alvarez J, Soriano E, Yuste VJ, Comella JX (2007) The long form of Fas apoptotic inhibitory molecule is expressed specifically in neurons and protects them against death receptor-triggered apoptosis. J Neurosci 27:11228-11241.
51. Shacka JJ, Roth KA (2006) Bcl-2 family and the central nervous system: from rheostat to real complex. Cell Death Differ 13:1299-1304.
52. Slevin JT, Gerhardt GA, Smith CD, Gash DM, Kryscio R, Young B (2005) Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line-derived neurotrophic factor. J Neurosurg 102:216-222.
53. Sun M, Kong L, Wang X, Lu XG, Gao Q, Geller AI (2005) Comparison of the capability of GDNF, BDNF, or both, to protect nigrostriatal neurons in a rat model of Parkinson's disease. Brain Res 1052:119-129.
54. Thorburn A (2004) Death receptor-induced cell killing. Cell Signal 16:139-144.
55. Troy CM, Rabacchi SA, Friedman WJ, Frappier TF, Brown K, Shelanski ML (2000) Caspase-2 mediates neuronal cell death induced by beta-amyloid. J Neurosci 20:1386-1392.
56. Ugolini G, Raoul C, Ferri A, Haenggeli C, Yamamoto Y, Salaün D, Henderson CE, Kato AC, Pettmann B, Hueber AO (2003) Fas/tumor necrosis factor receptor death signaling is required for axotomy-induced death of motoneurons in vivo. J Neurosci 23:8526-8531.
57. Yu LY, Arumäe U (2008) Survival assay of transiently transfected dopaminergic neurons. J Neurosci Methods 169:8-15.
58. Yu LY, Jokitalo E, Sun YF, Mehlen P, Lindholm D, Saarma M, Arumäe U (2003) GDNF-deprived sympathetic neurons die via a novel nonmitochondrial pathway. J Cell Biol 163:987-997.